About Douglas Watson
Douglas Watson is a lead independent director at Syncromune.
Douglas Watson reports to the SEC as a director of 8 public companies, including Orasure Technologies (OSUR), Wright Medical Group (WMGI) and Delcath Systems (DCTH).
Douglas Watson first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Douglas Watson in the role, so the role may have started earlier or lasted longer.
Syncromune, Inc.
Lead Independent Director
2022 – 2026 · Fort Lauderdale, FL
Develops investigational immune therapies for people with metastatic solid tumors.
OI
Orasure Technologies Inc.
Director
2006 – 2016 · Public company (OSUR)
WI
Wright Medical Group Inc.
Director
2013 – 2015 · Public company (WMGI)
DI
Delcath Systems, Inc.
Director
2010 – 2014 · Public company (DCTH)
DC
Dendreon Corp.
Director
2006 – 2014 · Public company (DNDNQ)
BI
Biomimetic Therapeutics, Inc.
Director
2006 – 2013 · Public company (BMTI)
GD
Genta Inc. De/
Director
2006 – 2010 · Public company (GNTA)
JI
Javelin Pharmaceuticals, Inc.
Director
2006 – 2010 · Public company (JAV)
EC
Engelhard Corp.
Director
2006 · Public company (EC)
Key Colleagues at Startups
The people Douglas Watson works with at each company, as listed on that company's latest Form D.
Syncromune, Inc. · Form D/A, May 11, 2026
JG
Joseph Gerardi
Executive officer
Jeffrey Cleland
Director
JM
Joseph Maroon
Director
Stephen Dale
Chief Medical Officer
NS
Norman Schwartz
Director
Charles Link
Executive Chairman & Chief Innovation Officer
Eamonn Hobbs
President & Chief Executive Officer, director
Kerri-Ann Millar
Chief Financial Officer
Agustin Gago
Chief Operating Officer